We are live on ! Find out more
KLDO

Kaleido Biosciences, Inc. Common Stock
KLDO

Delisted

KLDO was delisted on the 14th of April, 2022.

Back to rankings

2 hedge funds and large institutions have $2 invested in Kaleido Biosciences, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BHWM
Bay Harbor Wealth Management
Maryland
+$2

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BHWM
1
Bay Harbor Wealth Management
Maryland
$2 +$2 +2,300 New

KLDO Hedge Fund Activity: Q1 2025 in Review

2 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Kaleido Biosciences, Inc. Common Stock (KLDO) for Q1 2025, worth a combined $2.

Buyers outnumbered sellers: 2 funds opened new KLDO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bay Harbor Wealth Management, opening a new position worth an estimated $2.

  • 2 institutional investors held Kaleido Biosciences, Inc. Common Stock (KLDO) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $2 of Kaleido Biosciences, Inc. Common Stock stock for Q1 2025.
  • 2 funds opened new Kaleido Biosciences, Inc. Common Stock positions in Q1 2025 and 0 closed out, a net change of +2 holders.
  • The largest Kaleido Biosciences, Inc. Common Stock buyer in Q1 2025 was Bay Harbor Wealth Management, an estimated $2 added.

Based on aggregated 13F filings for Q1 2025.